Important Dates

Abstract Submission is Open

Travel Awards are Open

Registration Opens:
January 3, 2019

Abstract Submission and Travel Awards Close 
January 15, 2019, 5:00 p.m. (ET)

ASM Microbe 2019 Co-Chairs

David Relman, MD
Co-Chair, Stanford University, Palo Alto, California

David Aronoff, MD, FIDSA, FAAM
Co-Chair, Vanderbilt University, Nashville, Tennessee

Program Committee

Meeting Location 

Moscone Center
747 Howard St.
San Francisco, CA 94103


Antimicrobial Agents and Resistance

AARAntimicrobial Agents and Resistance (AAR) — One of our major health challenges today is the rising tide of antimicrobial resistance, with the emergence of "untreatable" microbes causing diseases that were once readily treatable. Find information regarding new antimicrobial agent discovery, preclinical investigations of new antimicrobial drugs in the pipeline, and first-look data of human clinical trials using new antimicrobial agents.



AAR01: Surveillance of Antimicrobial Resistance: Molecular Typing, Clinical and Molecular Epidemiology

AAR02: Antimicrobial Agents: Mechanisms of Action and Mechanisms of Resistance 

AAR03: Antifungal Agents and Resistance 

AAR04: Antiviral Agents (including HIV Drugs) and Resistance

AAR05: Antimicrobial Stewardship, including Quality of Care

AAR06: Novel Approaches: Therapies, Diagnostics and Drug Discovery

AAR07: Antimicrobial Pharmacokinetics, Pharmacodynamics and General Pharmacology

AAR08: New Antimicrobial Agents (Pre-US IND or Prior to the Start of Clinical Therapeutic Studies/pre-phase 2) and New Research Technologies 

AAR09: Pharmacological Studies of Antimicrobial Agents Pre-NDA  


Attend Innovative Sessions

Antimicrobial Agents Lecture (formerly known as the ICAAC Lecture)
June 22, 2019 • 1:30 p.m. – 4:00 p.m. 

Antibiotic Effects Beyond Killing
June 24, 2019 • 8:30 a.m. – 11:00 a.m. 


Want more? View all sessions in this track!